Tumor cells upregulate normoxic HIF-1α in response to doxorubicin
Hypoxia-inducible factor 1 (HIF-1) is a master transcription factor that controls cellular homeostasis. Although its activation benefits normal tissue, HIF-1 activation in tumors is a major risk factor for angiogenesis, therapeutic resistance, and poor prognosis. HIF-1 activity is usually suppressed...
Main Authors: | Cao, Y, Eble, JM, Moon, EJ, Yuan, H, Weitzel, DH, Landon, CD, Yu-Chih Nien, C, Hanna, G, Rich, JN, Provenzale, JM, Dewhirst, MW |
---|---|
Format: | Journal article |
Language: | English |
Published: |
American Association for Cancer Research
2013
|
Similar Items
-
Korean Red Ginseng-Induced SIRT3 Promotes the Tom22–HIF-1α Circuit in Normoxic Astrocytes
by: Hyungsu Kim, et al.
Published: (2023-05-01) -
Normoxic Tumour Extracellular Vesicles Modulate the Response of Hypoxic Cancer and Stromal Cells to Doxorubicin In Vitro
by: Laura Patras, et al.
Published: (2020-08-01) -
NADPH oxidase-mediated reactive oxygen species production activates hypoxia-inducible factor-1 (HIF-1) via the ERK pathway after hyperthermia treatment
by: Moon, EJ, et al.
Published: (2010) -
Normoxic HIF-1α Stabilization Caused by Local Inflammatory Factors and Its Consequences in Human Coronary Artery Endothelial Cells
by: Mohsen Abdi Sarabi, et al.
Published: (2022-12-01) -
Analysis of HIF-1 inhibition by manassantin A and analogues with modified tetrahydrofuran configurations
by: Kasper, AC, et al.
Published: (2009)